IP Verse

Actelion Pharmaceuticals Ltd opposition analysis

COMPANY ANALYSIS

Latest patents of Actelion Pharmaceuticals Ltd opposed by its competitors

Patent:
EP3256125
Grant Date:
Jan 26, 2022
Title:
Dosing Regimen For A Selective S1P1 Receptor Agonist
Oppositions:
2
Patent:
EP3592391
Grant Date:
Apr 21, 2021
Title:
Pharmaceutical Composition Comprising Selexipag
Oppositions:
1
Patent:
EP3300729
Grant Date:
Oct 9, 2019
Title:
Therapeutic Compositions Containing Macitentan
Oppositions:
3
Patent:
EP2315587
Grant Date:
Oct 25, 2017
Title:
Therapeutic Compositions Containing Macitentan
Oppositions:
5

Competitors of Actelion Pharmaceuticals Ltd

GENERICS (UK) LTD

STADA ARZNEIMITTEL AG

AERA A/S

Want to track Actelion Pharmaceuticals Ltd?

Feel free to send us a message here and we will get back to you